Anti-Cisplatin modified DNA, Recombinant [CP9/19] | Ximbio 152732 product information

product summary

company name :

Ximbio

product type :

antibody

product name :

Anti-Cisplatin modified DNA, Recombinant [CP9/19]

catalog :

152732

clonality :

polyclonal

host :

rat

conjugate :

nonconjugated

clone name :

CP9/19

reactivity :

human

application :

ELISA, immunohistochemistry, immunoprecipitation

more info or order :

Ximbio product webpage

product information

Name :

Anti-Cisplatin modified DNA, Recombinant [CP9/19]

Catalogue Number :

152732

Applications :

ELISA IHC IP DB

Antigen/Gene or Protein Targets :

Cisplatin modified native DNA

Relevance :

This antibody enables the quantification of cisplatin-induced adducts on DNA. This antibody has also been recently used for isolation of DNA fragments carrying adducts to enhance the sensitivity of subsequent PCR-based analyses and is central to ongoing studies of variation in the nature of cisplatin adducts formed in different cell lines. Antibody CP9/19 recognises only the intra-strand cross-links formed by cisplatin between adjacent purines.

Host :

Rat

Subclass :

IgG2a kappa

Positive Control :

RNA/DNA

Research Area :

DNA Damage and Repair, Epigenetics & Nuclear Signalling

Notes :

Recombinant monoclonal antibody produced from the original monoclonal. Manufactured using Absolute Antibody’s Recombinant Platform with variable regions (i.e. specificity) from the hybridoma.

more info or order :

Ximbio product webpage